CT52923

CAS: 205256-55-9 货号: C650187 分子式: C23H25N5O4S 分子量: 467.54
有货
级别和纯度: ≥98%
储存条件
避光,-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
5mg
C650187-5mg
期货 Stock Image
¥900.90
10mg
C650187-10mg
期货 Stock Image
¥1,400.90
25mg
C650187-25mg
期货 Stock Image
¥2,800.90
50mg
C650187-50mg
期货 Stock Image
¥4,500.90
100mg
C650187-100mg
期货 Stock Image
¥6,800.90
请输入您要添加的产品数量

概述


CT52923 is a selective, orally active platelet-derived growth factor receptor (PDGFR) antagonist. CT52923 also is an ATP-competitive inhibitor. CT52923 can be used for the research variety of pathological diseases, including atherosclerosis, glomerulonephritis, liver cirrhosis, pulmonary fibrosis, and cancer.

In Vitro

CT52923 inhibit the PDGFRs and stem cell factor receptor with an IC 50 value of 100 to 200 nM. CT52923 (0.01-30 μM; 24 h) blocks plateletderived growth factor-induced smooth muscle cell migration or fibroblast proliferation with an IC 50 of 64 and 280 nM, respectively. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Migration AssayCell Line: Rat A10 smooth muscle cells Concentration: 0.01-30 μM Incubation Time: 24 h Result: Inhibited PDGF-induced cell migration with an IC 50 of 64 nM.

In Vivo

CT52923 (oral; 5, 15, 30, and 50 mg/kg; twice daily) can significantly inhibit neointima formation following carotid artery injury by oral administration in the rat . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Rat carotid artery balloon angioplasty model . Dosage: 5, 15, 30, and 50 mg/kg Administration: Oral gavage; twice daily Result: Inhibited PDGF-mediated response to vascular injury.

Form:Solid

规格

规格或纯度
≥98%
英文名称
CT52923
生化机理
CT52923 是一种选择性、口服活性血小板衍生生长因子受体 (PDGFR) 拮抗剂。CT52923 还是一种 ATP 竞争性抑制剂。CT52923 可用于各种病理疾病的研究,包括动脉粥样硬化、肾小球肾
储存条件
避光,-80℃储存
运输条件
特低温运输
作用类型
拮抗剂
纯度
≥98%
名称和识别符
分子类型
小分子
分子量
467.54

高级数据

质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器